Arterial Pressure
Conditions
Interventions
This is a randomized, open, controlled clinical trial with two arms (control and experimental). We calculated that randomizing 100 participants would provide at least 90% power (2-sided alpha of 0.05)
F02.880.705
Sponsors
Liga de Hipertensão Arterial da Universidade Federal de Goiás
Liga de Hipertensão Arterial da Universidade Federal de Goiás
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Hypertensive adults (stage 1 or 2) with low and moderate cardiovascular risk, on stable use of antihypertensive medication for more than thirty days, evaluated by pressure measurements of the last visit.
Exclusion criteria
Exclusion criteria: Stage 3 patient hypertensive
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome1: Systolic blood pressure reduction of at least 3mmHg in the experimental group;Reached outcome 1: Systolic blood pressure reduction of 7.6 mmHg in the experimental group | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: Improvement of central blood pressure.;Expected outcome 3: Improvement of pulse wave velocity.;Expected outcome 4: Improvement of flow-mediated dilation.;Reached outcome 4: Increase of 4.1 percentage points of flow-mediated dilation;Reached outcome 2: no improvement in central blood pressure was observed;Reached outcome 3: no improvement in pulse wave velocity was observed | — |
Countries
Brazil
Contacts
Public ContactPriscila Vitorino
Liga de Hipertensão Arterial da Universidade Federal de Goiás
Outcome results
None listed